The Klinique Medical Clinic PCL (BKK:KLINIQ)
32.75
0.00 (0.00%)
Oct 19, 2026, 4:36 PM ICT
BKK:KLINIQ Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, BKK:KLINIQ stock has a consensus rating of "Strong Buy" and an average price target of ฿37.19. The average 1-year stock price forecast is 13.56% higher than the current stock price, while the lowest is ฿34.00 (+3.82%) and the highest is ฿40.00 (+22.14%).
Price Target: ฿37.19 (+13.56%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for BKK:KLINIQ stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 1 | 2 | 2 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 2 | 3 | 3 | 4 |
Financial Forecast
Revenue This Year
4.62B
from 3.56B
Increased by 29.96%
Revenue Next Year
5.37B
from 4.62B
Increased by 16.16%
EPS This Year
2.20
from 1.65
Increased by 33.54%
EPS Next Year
2.59
from 2.20
Increased by 17.70%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is THB.